— Know what they know.
Not Investment Advice

PTPI Earnings

Petros Pharmaceuticals, Inc.
1W: -6.2% 1M: -20.2% 3M: -23.5% YTD: -53.1% 1Y: -85.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+13.64%)
 
Weekly Expected Move ±50.8%
$-0 $0 $0 $0 $0
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 43 · $158896 mcap · 29M float · 0.411% daily turnover · Short 47% of daily vol
Last Earnings 2026-05-13
EPS
$-0.03
▼ Miss +0.0%
Revenue
—
Next Earnings 2026-12-02
EPS Estimate
$-42.25
Range: $-42.25 - $-42.25
Revenue Estimate
$1M
1 analysts

Estimate vs Actual

Earnings Surprise History

0/2
EPS Beats
0/2
Revenue Beats
0%
EPS Beat Rate
0%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-09-07 quarter 2027-12-30 $— $-8.25 ▼ 8.25 $— $1,283,000
2026-09-07 quarter 2027-09-30 $-8.25 $-7.25 ▲ 1.00 $1,283,000 $1,340,000
2026-09-07 quarter 2027-06-30 $-7.25 $-9.25 ▼ 2.00 $1,340,000 $1,421,000
2026-09-07 quarter 2027-03-30 $-9.25 $-42.25 ▼ 33.00 $1,421,000 $1,388,806
2026-08-20 quarter 2026-03-31 $— $-8.25 ▼ 8.25 $— $1,283,000
2026-08-20 quarter 2025-12-31 $— $-7.25 ▼ 7.25 $— $1,340,000
2026-08-20 quarter 2025-09-30 $— $-9.25 ▼ 9.25 $— $1,421,000
2026-08-20 quarter 2025-06-30 $— $-42.25 ▼ 42.25 $— $1,388,806
2026-08-14 quarter 2027-03-30 $— $-9.25 ▼ 9.25 $— $1,421,000
2026-08-14 quarter 2026-12-30 $— $-42.25 ▼ 42.25 $— $1,388,806
2026-08-12 quarter 2024-03-31 $— $-42.25 ▼ 42.25 $— $1,388,806
2026-08-12 quarter 2023-12-31 $— $-1.11 ▼ 1.11 $— $1,553,000
2026-07-17 quarter 2027-06-30 $— $-7.25 ▼ 7.25 $— $1,340,000
2026-07-17 quarter 2027-09-30 $— $-8.25 ▼ 8.25 $— $1,283,000
2026-07-17 quarter 2026-12-31 $— $-42.25 ▼ 42.25 $— $1,388,806
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms